Clinical trial
Trial to Evaluate the Immune Response to OPV When Administered Concomitantly…
NCT00192426 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192426 |
|---|---|
| Title | Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children. |
| Official title | A Prospective, Randomized, Partially-Blinded, Placebo-Controlled, Phase III, Multicenter Trial to Assess Safety, Tolerability and Immunogenicity of Liquid CAIV-T Administered Concomitantly With OPV in Healthy Children |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | CAIV-T |
| Enrollment | 2,400 |
| Start date | Sep 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 3, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: